MedCity News November 21, 2024
Marissa Plescia

Experts aren’t sure what the outcome of the DOJ’s recent lawsuit against the proposed UnitedHealth Group/Amedisys merger will be under the incoming Trump administration. The Biden administration has focused more on supporting clinicians, while the previous Trump administration favored corporations. Additionally, one expert noted that this case differs from other antitrust lawsuits because it does not seem to focus on a potential price increase.

Yet another shoe has dropped in the UnitedHealth Group/Amedisys saga. Last week, the Justice Department — along with the Attorneys General of Maryland, Illinois, New Jersey, and New York — filed a lawsuit to block UHG’s $3.3 billion acquisition of home health and hospice company Amedisys through Optum.

In 2023, UnitedHealth Group’s Optum announced that it...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Govt Agencies, Insurance, Mergers & Acquisitions / JV, Payer, Post-Acute Care, Provider, Trends
Related Articles:
Village Caregiving Expands Once Again, Bringing Its Footprint Into 22 States
New C-Suite Executives Tapped to Lead Hospices in 2025
Providence’s Joint Venture With Compassus Likely Delayed Amid Concerns About Patient Care And Rural Access
Joining Forces: 2024’s Hospice Investment, Consolidation Trends
Ensign Enters Oregon, Alaska with Providence Portfolio Acquisition

Share This Article